相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Application of medium-term metrics for assessing glucose homoeostasis: Usefulness, strengths and weaknesses
L. Monnier et al.
DIABETES & METABOLISM (2021)
Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study
Jan Soupal et al.
DIABETES CARE (2020)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Number Needed-to-Treat (NNT): Is it a necessary marker of therapeutic efficiency?
L. Monnier et al.
DIABETES & METABOLISM (2020)
Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?
Louis Monnier et al.
DIABETES CARE (2020)
The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications
David R. Owens et al.
DIABETES OBESITY & METABOLISM (2020)
Blood Pressure Variability and Risk of Heart Failure in ACCORD and the VADT
Daniel S. Nuyujukian et al.
DIABETES CARE (2020)
Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial
Chang-Sheng Sheng et al.
DIABETES CARE (2020)
Glucose Variability and Diabetic Complications: Is It Time to Treat?
Antonio Ceriello
DIABETES CARE (2020)
Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial
Matthew W. Segar et al.
DIABETES CARE (2020)
Body Weight Variability and the Risk of Cardiovascular Outcomes and Mortality in Patients With Type 2 Diabetes: A Nationwide Cohort Study
Ga Eun Nam et al.
DIABETES CARE (2020)
The Association Between HbA1cand Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)
Shilan Seyed Ahmadi et al.
DIABETES CARE (2020)
Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study
Francesco Zaccardi et al.
DIABETOLOGIA (2020)
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes A Randomized Clinical Trial
Richard E. Pratley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes A Randomized Clinical Trial
Lori M. Laffel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Statistical and clinical significances: Are they equivalent?
L. Monnier et al.
DIABETES & METABOLISM (2020)
Indispensable but deceptive evidence-based medicine Comment
Christian Funck-Brentano
DIABETES & METABOLISM (2020)
Visit-to-Visit Hemoglobin A1cVariability Is Associated With the Risk of Lower-Extremity Amputation in Patients With Type 2 Diabetes
Yuxin Fan et al.
DIABETES CARE (2020)
Glucocentric risk factors for macrovascular complications in diabetes: Glucose 'legacy' and 'variability'-what we see, know and try to comprehend
L. Monnier et al.
DIABETES & METABOLISM (2019)
Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study
Antonio Ceriello et al.
DIABETES CARE (2019)
Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management
Stephanie A. Amiel et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Comment on Echouffo-Tcheugui et al. Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study. Diabetes Care 2019;42:486-493
Louis Monnier et al.
DIABETES CARE (2019)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein et al.
LANCET (2019)
Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study
Jae-Seung Yun et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Variability in Glycated Hemoglobin and Risk of Poor Outcomes Among People With Type 2 Diabetes in a Large Primary Care Cohort Study
Julia A. Critchley et al.
DIABETES CARE (2019)
Glycaemic variability in diabetes: clinical and therapeutic implications
Antonio Ceriello et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study
Justin B. Echouffo-Tcheugui et al.
DIABETES CARE (2019)
Body-Weight Fluctuation and Incident Diabetes Mellitus, Cardiovascular Disease, and Mortality: A 16-Year Prospective Cohort Study
Tae Jung Oh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
Scott M. Grundy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A. Zelniker et al.
LANCET (2019)
Visit-to-Visit Variability of Blood Pressure Is Associated With Hospitalization and Mortality in an Unselected Adult Population
Marc D. Basson et al.
AMERICAN JOURNAL OF HYPERTENSION (2018)
Platelet function following induced hypoglycaemia in type 2 diabetes
H. Kahal et al.
DIABETES & METABOLISM (2018)
Glucose variability: Do we have to revisit the profusion of definitions to avoid confusion?
L. Monnier et al.
DIABETES & METABOLISM (2018)
The application of simple metrics in the assessment of glycaemic variability
L. Monnier et al.
DIABETES & METABOLISM (2018)
Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits
Beatrice C. Lupsa et al.
DIABETOLOGIA (2018)
Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks
Maria H. Mehlum et al.
EUROPEAN HEART JOURNAL (2018)
Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study
Angus Forbes et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Adrian F. Hernandez et al.
LANCET (2018)
DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality
Thomas R. Pieber et al.
DIABETOLOGIA (2018)
Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)
Bernard Zinman et al.
DIABETOLOGIA (2018)
The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes
Alexandra K. Lee et al.
DIABETES CARE (2018)
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum
William T. Cefalu et al.
DIABETES CARE (2018)
Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes
Louis Monnier et al.
DIABETES CARE (2017)
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial
Marcus Lind et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial
Roy W. Beck et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Metrics for glycaemic control - from HbA1c to continuous glucose monitoring
Boris P. Kovatchev
NATURE REVIEWS ENDOCRINOLOGY (2017)
International Consensus on Use of Continuous Glucose Monitoring
Thomas Danne et al.
DIABETES CARE (2017)
Effects on cardiovascular risk factors of weight losses limited to 5-10 %
Joshua D. Brown et al.
TRANSLATIONAL BEHAVIORAL MEDICINE (2016)
Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk
DIABETES CARE (2016)
Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk. Diabetes Care 2016;39:973-981
Louis Monnier et al.
DIABETES CARE (2016)
Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up
Rose A. Gubitosi-Klug et al.
DIABETES CARE (2016)
Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study
Jan Soupal et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2016)
Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease
Elvira O. Gosmanova et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Blood pressure variability and cardiovascular disease: systematic review and meta-analysis
Sarah L. Stevens et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Blood pressure variability and cardiovascular disease: systematic review and meta-analysis
Sarah L. Stevens et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Association Between Severe Hypoglycemia and Cardiovascular Disease Risk in Japanese Patients With Type 2 Diabetes
Atsushi Goto et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Risk of and risk factors for hypoglycemia and associated arrhythmias in patients with type 2 diabetes and cardiovascular disease: a cohort study under real-world conditions
Frank Pistrosch et al.
ACTA DIABETOLOGICA (2015)
Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality A Cohort Study
Paul Muntner et al.
ANNALS OF INTERNAL MEDICINE (2015)
Cardiovascular Implications of Hypoglycemia in Diabetes Mellitus
Kim A. Connelly et al.
CIRCULATION (2015)
Treatment of Hypertension in Patients With Coronary Artery Disease A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension
Clive Rosendorff et al.
CIRCULATION (2015)
Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial
Juris J. Meier et al.
DIABETES CARE (2015)
Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis
Catherine Gorst et al.
DIABETES CARE (2015)
Mild dysglycemia in type 2 diabetes: to be neglected or not?
Louis Monnier et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)
Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes
Rodney A. Hayward et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Glycemic Goals in Diabetes: Trade-off Between Glycemic Control and Iatrogenic Hypoglycemia
Philip E. Cryer
DIABETES (2014)
Relationship Between Hypoglycemic Episodes and Ventricular Arrhythmias in Patients With Type 2 Diabetes and Cardiovascular Diseases: Silent Hypoglycemias and Silent Arrhythmias
Annett Stahn et al.
DIABETES CARE (2014)
Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial
Yoichiro Hirakawa et al.
DIABETES CARE (2014)
Association Between Severe Hypoglycemia, Adverse Macrovascular Events, and Inflammation in the Edinburgh Type 2 Diabetes Study
Rachel Bedenis et al.
DIABETES CARE (2014)
Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes
Michaela Diamant et al.
DIABETES CARE (2014)
Glycemic Variability Is Higher in Type 1 Diabetes Patients with Microvascular Complications Irrespective of Glycemic Control
Jan Soupal et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2014)
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
Syed S. Mahmood et al.
LANCET (2014)
Impact of weight cycling on risk of morbidity and mortality
T. Mehta et al.
OBESITY REVIEWS (2014)
Differential effects of GLP-1 receptor agonists on components of dysglycaemia in individuals with type 2 diabetes mellitus
D. R. Owens et al.
DIABETES & METABOLISM (2013)
Relationships between metrics of visit-to-visit variability of blood pressure
E. B. Levitan et al.
JOURNAL OF HUMAN HYPERTENSION (2013)
被撤回的出版物: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet (Retracted article. See vol. 378, pg. 2441, 2018)
Ramon Estruch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: Results from the randomized Optima study
B. Guerci et al.
DIABETES & METABOLISM (2012)
The glycemic triumvirate and diabetic complications: Is the whole greater than the sum of its component parts?
Louis Monnier et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Serious Cardiovascular Outcomes in Diabetes The Role of Hypoglycemia
Natalia Yakubovich et al.
CIRCULATION (2011)
Hypoglycemia and Cardiovascular Risks
Brian M. Frier et al.
DIABETES CARE (2011)
The Contribution of Glucose Variability to Asymptomatic Hypoglycemia in Persons with Type 2 Diabetes
Louis Monnier et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy
L. Monnier et al.
DIABETOLOGIA (2010)
The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence
C. Nordin
DIABETOLOGIA (2010)
Glucose Variability; Does It Matter?
Sarah E. Siegelaar et al.
ENDOCRINE REVIEWS (2010)
Blood Pressure Variability Clarity for Clinical Practice
Eamon Dolan et al.
HYPERTENSION (2010)
Severe Hypoglycemia and Risks of Vascular Events and Death.
Sophia Zoungas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial
Itamar Raz et al.
DIABETES CARE (2009)
Insulin as an Anti-Inflammatory and Antiatherogenic Modulator
Paresh Dandona et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Glycemic variability: A strong independent predictor of mortality in critically ill patients
James S. Krinsley
CRITICAL CARE MEDICINE (2008)
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients
Antonio Ceriello et al.
DIABETES (2008)
A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes Data from the Diabetes Control and Complications Trial
Eric S. Kilpatrick et al.
DIABETES CARE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of a multifactorial intervention on mortality in type 2 diabetes
Peter Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes
I. M. E. Wentholt et al.
DIABETOLOGIA (2008)
The effect of glucose variability on the risk of microvascular complications in type 1 diabetes
Eric S. Kilpatrick et al.
DIABETES CARE (2006)
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic Hyperglycemia in patients with type 2 diabetes
L Monnier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Insulin glargine or NPH combined with metformin in type 2 diabetes:: the LANMET study
H Yki-Järvinen et al.
DIABETOLOGIA (2006)
Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus
MY Rady et al.
MAYO CLINIC PROCEEDINGS (2005)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
C-reactive protein levels following acute myocardial infarction - Effect of insulin infusion and tight glycemic control
VW Wong et al.
DIABETES CARE (2004)
A Probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus - The diabetes outcomes in veterans study (DOVES)
GH Murata et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
P Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients
JS Krinsley
MAYO CLINIC PROCEEDINGS (2003)
The treat-to-target trial - Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
MC Riddle et al.
DIABETES CARE (2003)
Role of hyperglycemia in nitrotyrosine postprandial generation
A Ceriello et al.
DIABETES CARE (2002)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
AI Adler et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
分享论文
